Sherbrooke Park Advisers LLC Castle Biosciences Inc Transaction History
Sherbrooke Park Advisers LLC
- $313 Billion
- Q4 2024
A detailed history of Sherbrooke Park Advisers LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Sherbrooke Park Advisers LLC holds 12,372 shares of CSTL stock, worth $254,120. This represents 0.11% of its overall portfolio holdings.
Number of Shares
12,372
Previous 14,161
12.63%
Holding current value
$254,120
Previous $404 Million
18.36%
% of portfolio
0.11%
Previous 0.09%
Shares
3 transactions
Others Institutions Holding CSTL
# of Institutions
210Shares Held
26.6MCall Options Held
128KPut Options Held
35.4K-
Black Rock Inc. New York, NY3.04MShares$62.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$37.6 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.8MShares$36.9 Million0.24% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.44MShares$29.5 Million0.02% of portfolio
-
Dimensional Fund Advisors LP Austin, TX999KShares$20.5 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $540M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...